Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Ideas
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Tools
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Portfolio
News
Enterprise Solutions
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us
More
Plans
News
Trending
Portfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Ideas
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Tools
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us
Log Out
Company Announcements
AstraZeneca’s FluMist: Self-Administered Flu Vaccine Approved
4h ago
Premium
The Fly
AstraZeneca confirms FluMist approved for self-administration in U.S.
4h ago
AZN
Premium
The Fly
FDA approves AstraZeneca’s FluMist for self- or caregiver-administration
5h ago
AZN
Premium
The Fly
AIM reports preliminary data in Phase 1b/2 study of Ampligen, Imfinzi
1d ago
AIM
AZN
Premium
The Fly
AstraZeneca’s Fasenra approved in U.S. to treat adults with EGPA
2d ago
AZN
Premium
Company Announcements
AstraZeneca’s Fasenra Wins FDA Approval for Rare Vasculitis
3d ago
Premium
The Fly
AstraZeneca announces HIMALAYA trial demonstrated overall survival benefit
4d ago
AZN
Premium
The Fly
AstraZeneca announces updated results from HIMALAYA Phase III trial of Imjudo
4d ago
AZN
Premium
Company Announcements
AstraZeneca Chair Shows Confidence with Share Purchase
7d ago
Premium
The Fly
AstraZeneca says ENHERTU achieved 61.6% progression-free survival rate in study
7d ago
AZN
Premium
The Fly
Deutsche downgrades AstraZeneca to Sell on challenging risk/reward
8d ago
AZN
Premium
The Fly
AstraZeneca downgraded to Sell from Hold at Deutsche Bank
8d ago
AZN
Premium
The Fly
Salesforce downgraded, Charter upgraded: Wall Street’s top analyst calls
9d ago
AR
MS
Premium
The Fly
Erste upgrades AstraZeneca to Buy on strong oncology sales growth
9d ago
AZN
Premium
The Fly
AstraZeneca upgraded to Buy from Hold at Erste Group
9d ago
AZN
Premium
The Fly
AstraZeneca downgraded to Sell from Hold at Nordea
10d ago
AZN
Premium
Market News
AstraZeneca Shares Fall on Lung Cancer Drug Trial’s Outcome
10d ago
AZN
Premium
The Fly
Sophia Genetics announces collaboration agreement with AstraZeneca
10d ago
AZN
SOPH
Premium
The Fly
J&J Rybrevant/Lazcluze study shows superiority over lazertinib for NSCLC
11d ago
AZN
JNJ
Premium
The Fly
AstraZeneca says Dato-DXd showed clinically meaningful trend toward improving OS
11d ago
AZN
Premium
The Fly
AstraZeneca put volume heavy and directionally bearish
11d ago
AZN
Premium
The Fly
Innate Pharma reports AstraZeneca presentation of results from NeoCOAST-2 study
11d ago
AZN
IPHA
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
